
Explore the global preclinical antibacterial pipeline, discussing progress, challenges, and opportunities in antibiotic discovery with WHO expert Valeria Gigante and AAC Editor Cesar Arias.

Exploring innovative treatments for opioid overdose beyond Naloxone, including receptor combos, antibodies, and nanoparticles to address limitations with potent opioids like fentanyl.

Explore the critical role of in vitro ADME and drug-drug interaction studies in early drug development, their impact on decision-making, and how they help avoid unnecessary clinical studies and costs.

Explore cellular assays for predicting protein therapeutic disposition, focusing on target-independent mechanisms affecting pharmacokinetics and strategies to identify optimal drug candidates.

Explore MedTech startup opportunities with the European Medicines Agency (EMA) in this comprehensive seminar for the EIC MedTech/MedDev community.

Explore past, present, and future perspectives on GLP-1 agonists with expert insights from Stanford's endocrinology professor Dr. Dimpi Desai.

Explore the latest advancements in antibody-drug conjugates (ADCs) for treating non-small cell lung cancer, focusing on their efficacy, safety, and potential to revolutionize NSCLC therapy.

Explore the complex factors behind high drug prices, including market fragmentation, profit motives, and regulations. Discuss potential solutions and the role of venture capital in balancing innovation with affordability.

Explore AI's transformative role in drug discovery with Isomorphic Labs experts, discussing challenges, innovations, and future prospects in biotech and healthcare.

Explore how data-driven approaches and advanced statistical methods optimize drug behavior analysis and therapeutic strategies for personalized healthcare outcomes and improved treatment effectiveness.

Explore the fundamentals of drug development, from initial research through clinical trials and regulatory approval processes in this comprehensive pharmaceutical sciences overview.

Explore how clinical trials are evolving post-pandemic through digital capabilities, decentralized models, and streamlined data systems to accelerate medical research and treatment development.

Discover groundbreaking research on PXS-5505, a novel inhibitor that enhances chemotherapy effectiveness in pancreatic cancer treatment through innovative tumor microenvironment modification.

Explore Carol Robinson's groundbreaking research in structural biology, focusing on protein interactions in the vapor phase and its impact on understanding human health and drug development.

Explore innovative approaches to accelerate drug development: repurposing existing medications and testing on artificial human tissue. Gain insights from NIH Director on revolutionizing disease treatments.

Nobel laureate Dr. Lefkowitz shares his journey from reluctant scientist to groundbreaking researcher, exploring pivotal moments and lessons learned that led to his revolutionary work on G-protein coupled receptors.

Exploring strategies to enhance clinical trials through improved accessibility, diversity, and data collection efficiency, leading to faster development of therapies for a broader population.

Explore the journey of CRISPR gene editing technology from lab to FDA-approved therapy, uncovering challenges and timelines in drug development for groundbreaking medical treatments.

Exploring the evolution of cancer research from ancient Islamic wisdom to modern clinical trials, highlighting the transformative impact on patient care and the holistic approach to healing.

Explore recent breakthroughs in pharmacy and medicine, focusing on innovative treatments and their impact on patient care and healthcare practices.

Dr. Nusrat Sanghamitra shares her inspiring journey from humble beginnings to groundbreaking cancer research, highlighting resilience, innovation, and the power of turning dreams into action in biotechnology.